BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32000861)

  • 1. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
    Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
    Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
    Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
    Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
    J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
    Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
    BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of Clinically-Relevant Rare Variants in
    Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
    Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort.
    Roman Y; Tiirikainen M; Prom-Wormley E
    Clin Rheumatol; 2020 Aug; 39(8):2387-2392. PubMed ID: 32107664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
    Eckenstaler R; Benndorf RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
    Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
    Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
    Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
    Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
    Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case-control study.
    Natsuko PD; Laura SC; Denise CC; Lucio VR; Carlos AS; Fausto SM; Ambar LM
    Eur J Med Res; 2022 May; 27(1):62. PubMed ID: 35505381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.
    Nakayama A; Matsuo H; Nakaoka H; Nakamura T; Nakashima H; Takada Y; Oikawa Y; Takada T; Sakiyama M; Shimizu S; Kawamura Y; Chiba T; Abe J; Wakai K; Kawai S; Okada R; Tamura T; Shichijo Y; Akashi A; Suzuki H; Hosoya T; Sakurai Y; Ichida K; Shinomiya N
    Sci Rep; 2014 Jun; 4():5227. PubMed ID: 24909660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge.
    Dalbeth N; House ME; Gamble GD; Pool B; Horne A; Purvis L; Stewart A; Merriman M; Cadzow M; Phipps-Green A; Merriman TR
    Arthritis Res Ther; 2014 Jan; 16(1):R34. PubMed ID: 24476385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional non-synonymous variants of ABCG2 and gout risk.
    Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K
    Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.
    Jing J; Ekici AB; Sitter T; Eckardt KU; Schaeffner E; Li Y; Kronenberg F; Köttgen A; Schultheiss UT
    Sci Rep; 2018 Sep; 8(1):13184. PubMed ID: 30181573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2.
    Toyoda Y; Pavelcová K; Klein M; Suzuki H; Takada T; Stiburkova B
    Arthritis Res Ther; 2019 Oct; 21(1):219. PubMed ID: 31661014
    [No Abstract]   [Full Text] [Related]  

  • 20. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.